ACHE and Alzheimer disease: As of now, there are only two FDA-approved classes of drugs used in the symptomatic treatment of AD: the noncompetitive NMDA antagonist memantine, and the acetylcholinesterase inhibitors, donepezil, galantamine and rivastigmine, with both classes of drugs having a synaptic site of action.